Neuroblastoma

Pediatric Surgery: Sixth Edition

Volumn 1-2, Issue , 2006, Pages 467-494

  Grosfeld, Jay L ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44949235050     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02842-4.50031-0     Document Type: Chapter

References (246)

1. Abrams HL, Siegelman SS, Adams DF, et al. Computed tomography versus ultrasound of the adrenal gland: A prospective study. Radiology 1982, 143:121-128.
2. Abramson SJ, Berdon WE, Ruzal-Shapiro C, et al. Cervical neuroblastoma in eleven infants a tumor with favorable prognosis: Clinical and radiologic (US, CTR, MRI) findings. Pediatr Radiol 1993, 23:253-257.
3. Acharya S, Jayabose S, Kogan S, et al. Prenatally diagnosed neuroblastoma. Cancer 1997, 80:304-310.
4. Adams GA, Shochat SJ, Smith EI, et al. Thoracic neuroblastoma: A pediatric oncology group study. J Pediatr Surg 1993, 28:372-377.
5. Adkins ES, Sawin R, Gerbing RB, et al. Efficacy of complete resection for high risk neuroblastoma: A Children's Cancer Group study. J Pediatr Surg 2004, 39:931-936.
6. Akeson R, Seeger RC Interspecies neural membrane antigens on cultured human and murine neuroblastoma cells. J Immunol 1977, 118:1995-2003.
7. Allen RW, Ogden B, Bentley FL, Jung AL Fetal hydantoin syndrome: Neuroblastoma and hemorrhagic disease in a neonate. JAMA 1980, 44:1464-1465.
8. Al-Rashid RA, Cress C Hypercalcemia associated with neuroblastoma. Am J Dis Child 1979, 133:838-841.
9. Altman A, Baehner RL Favorable prognosis for survival in children with coincident opsomyoclonus and neuroblastoma. Cancer 1976, 37:846-852.
10. Ambros IM, Attarbashi A, Rumpler S, et al. Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 2001, 36:163-168.
11. Ambros IM, Zellner A, Roald B, et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 1996, 334:1505-1511.
12. Anders D, Kindermann G, Pfeifer U Metastasizing fetal neuroblastoma with involvement of the placenta simulating fetal erythroblastosis. J Pediatr 1973, 82:50-53.
13. Beckwith JB, Perrin EV In-situ neuroblastoma: A contribution to the natural history of neural crest tumors. Am J Pathol 1963, 43:1089-1104.
14. Beirle EA, Strande LK, Chen MK VEGF upregulates bcl-2 expression and is associated with decreased apop-tosis in neuroblastoma cells. J Pediatr Surg 2002, 7:467-471.
15. Beppu K, Jaboine J, Merchant MS, et al. Effect of imatinib mesylate on neuroblastoma tumorigenesis and VEGF expression. J Natl Cancer Inst 2004, 96:46-55.
16. Bernardi J, et al. Prognostic value of MDR1 gene expression in neuroblastoma: Results of a multivariate analysis. Prog Clin Biol Res 1994, 385:111.
17. Bernstein I, Hellstrom KE, Wright PW, et al. Immunity to tumor antigens: Potential implications in human neuroblastoma. J Natl Cancer Inst 1976, 57:711-715.
18. Berthold F, Kassenböhmer R, Zieschang J Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Hematol Oncol 1994, 16:107-115.
19. Bessho F, Hashizume K, Nakajo T, et al. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 1991, 119:237-241.
20. Bill AH Immune aspects of neuroblastoma: Current information. Am J Surg 1971, 122:142-147.
21. Blatt JB, Deutsch M, Wollman MR Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly. Int J Radiat Oncol Biol Phys 1987, 13:1467-1471.
22. Blatt JB, Fitz G, Mirro J Recognition of central nervous system metastases in children with metastatic primary extracranial neuroblastoma. Pediatr Hematol Oncol 1997, 14:233-241.
23. Breslow N, McCann B Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 1971, 31:1098-1103.
24. Brock CE, Ricketts RR Hemoperitoneum from spontaneous rupture of neonatal neuroblastoma. Am J Dis Child 1982, 136:370-371.
25. Brodeur GM Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer 1995, 31A:505-510.
26. Brodeur GM Schwann cells as antineuroblastoma agents. N Engl J Med 1996, 334:1537-1539.
27. Brodeur GM Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-216.
28. Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis staging and response to treatment. J Clin Oncol 1993, 11:1466-1477.
29. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis of staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988, 6:1874-1881.
30. Caron H, van Sluis B, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996, 334:225-230.
31. Castel V, Bedal MD, Bezanilla JL, et al. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 1995, 34:29-35.
32. Castel VP, Heidelberger KP, Bromberg J, et al. Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993, 143:1543-1550.
33. Castleberry RP, Pritchard J, Ambros P, et al. The International Neuroblastoma Risk Groups (INRG): A preliminary report. Eur J Cancer 1997, 33:2113-2116.
34. Castleberry RP, Shuster JJ, Smith EI Pediatric Oncology Group experience with the International Staging System criteria for neuroblastoma. J Clin Oncol 1994, 12:2378-2381.
35. Chan HS, Haddad G, Thorner PS, et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991, 325:1608-1614.
36. Chang THT, Prasad KN Differentiation of mouse neuroblastoma cells in-vitro and in-vivo, induced by cyclic adenosine monophosphate (cAMP). J Pediatr Surg 1976, 11:847-858.
37. Chatten J, Voorhees ML Familial neuroblastoma: Report of a kindred with multiple disorders including neuroblastoma in four siblings. N Engl J Med 1967, 277:1230-1236.
38. Cheung NK Monclonal antibody-based therapy for neuroblastoma. Curr Oncol Rep 2000, 2:547-551.
39. Cheung NK, Kushner BH, Yeh SD, et al. 3F8 Monoclonal antibody treatment of patients with stage 4 neuroblastoma: A phase II study. Int J Oncol 1998, 12:1299-1306.
40. Chlenski A, Liu S, Cohn SL The regulation of angiogenesis in a neuroblastoma. Cancer Lett 2003, 197:47-52.
41. Coldman AJ, Fryer CJ, Elwood JM, Sonley MJ Neuroblastoma: Influence of age at diagnosis, stage, site and sex on prognosis. Cancer 1980, 46:1896-1901.
42. Cooney DR, Voorhees ML, Fisher JE, et al. Vasoactive intestinal polypeptide producing neuroblastoma. J Pediatr Surg 1982, 17:821-825.
43. Cushing H, Wolbach SB Transformation of malignant para-vertebral sympathicoblastoma into benign ganglioneuroma. Am J Pathol 1927, 3:203.
44. D'Angio GJ, Evans AE Experience with cyclic low-dose total body irradiation for metastatic neuroblastoma [abstract]. Proc Am Soc Clin Oncol 1982, 23:52.
45. D'Angio GJ, Evans AE, Koop CE Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1971, 1:1046-1049.
46. Dastur DK Cerebral ganglioglioneuroblastoma: An unusual brain tumor of the neuron series. J Neurol Neurosurg Psychiatry 1982, 45:139-142.
47. Davidoff AM, Kandel JJ Antiangiogenic therapy for the treatment of pediatric solid malignancies. Semin Pediatr Surg 2004, 13:53-60.
48. Davidoff AM, Leary MA, Ng CT, et al. Retroviral vector producer cell mediated angiogenesis inhibition restricts neuroblastoma growth in-vivo. Med Pediatr Oncol 2000, 35:638-640.
49. Davidoff AM, Leary MA, Ng CY, et al. Gene therapy mediated expression by tumor cells of the angiogenesis inhibitor Flk-1 results in inhibition of neuroblastoma growth in-vivo. J Pediatr Surg 2001, 36:30-36.
50. DeBernardi B, Pianca C, Boni L, et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life: Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer 1992, 70:1625-1633.
51. DeBernardi B, Conte M, Mancini A, et al. Localized resectable neuroblastoma: Results of the 2nd study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 1995, 13:884-893.
52. de Lagausie P, Berribi D, Michon J, et al. Laparoscopic adrenal surgery for neuroblastoma in children. J Urol 2003, 170:932-935.
53. Deutsch M, Tersak JM Radiotherapy for symptomatic metastases to bone in children. Am J Clin Oncol 2004, 27:128-131.
54. Dobrovoljski G, Kerbl R, Strobl C, et al. False-positive results in neuroblastoma screening: The parents' view. J Pediatr Hematol Oncol 2003, 25:14-18.
55. Dole M, Nunez G, Merchant AK, et al. Bcl-2 inhibits chemotherapy induced apoptosis in neuroblastoma. Cancer Res 1994, 54:3253-3259.
56. Dreyfus M, Neuhart D, Baldauf JJ, et al. Prenatal diagnosis of cystic neuroblastoma. Fetal Diagn Ther 1994, 9:269-272.
57. Eggert A, Ikegaki N, Kwiatkowski J, et al. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 2000, 6:1900-1908.
58. El-Shafie M, Samuel D, Klippel CH, et al. Intractable diarrhea in children with VIP-secreting ganglioneuroblastoma. J Pediatr Surg 1983, 18:34-36.
59. Emery LG, Shields M, Shah MR, et al. Neuroblastoma associated with Beckwith-Wiedemann syndrome. Cancer 1983, 52:176-179.
60. Entz-Werle N, Marcellin L, Becmeur F, et al. The urinary bladder: An extremely rare location of pediatric neuroblastoma. J Pediatr Surg 2003, 38:E10-E12.
61. Evans AE, Albo V, D'Angio GJ, et al. Cyclophosphamide treatment of patients with localized and regional neuroblastoma: A randomized study. Cancer 1976, 38:655-660.
62. Evans AE, D'Angio GJ, Randolph JG A proposed staging for children with neuroblastoma. Cancer 1971, 27:374-378.
63. Evans AE, Gerson J, Schnaufer L Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 1976, 44:49-54.
64. Evans AE, Heyn RN, Newton WA, Leikin SL Viscristine sulfate and cyclophosphamide for children with metastatic neuroblastoma. JAMA 1969, 207:1325-1327.
65. Fenart D, Deville A, Donzeau M, Bruneton JN Neuroblastome retroperitoneal diagnostique in utero. J Radiol 1983, 64:359-361.
66. Filler RM, Traggis DG, Jaffe N, Vawter GF Favorable outlook for children with mediastinal neuroblastoma. J Pediatr Surg 1972, 7:136-143.
67. Finklestein JZ, Klemperer MA, Evans AE, et al. Multiagent chemotherapy for children with metastatic neuroblastoma: A report from the Children's Cancer Study Group. Med Pediatr Oncol 1979, 6:179-188.
68. Fleitz JM, Wooten-Gorges SC, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma early in childhood. Pediatr Radiol 2003, 33:540-545.
69. French AE, Grant R, Weitzman S, et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol 2003, 74:288-294.
70. Gerson JM, Chatten J, Eisman S Familial neuroblastoma a follow-up. N Engl J Med 1974, 190:487.
71. Gerson JM, Herberman RB Systemic and in-situ natural killer activity in patients with neuroblastoma. Advances in Neuroblastoma Research 1980, Raven Press, New York. A.E. Evans (Ed.).
72. Green AA, Hayes FA, Hustu HO Sequential cyclophosphamide and doxorubicin for induction and complete remission in children with disseminated neuroblastoma. Cancer 1981, 48:2310-2317.
73. Grosfeld JL Neuroblastoma: A 1990 overview. Pediatr Surg Int 1991, 6:9-13.
74. Grosfeld JL Risk based management of childhood solid tumors. J Am Coll Surg 1999, 189:407-425.
75. Grosfeld JL, Ballantine TVN, Baehner RL Experience with "second-look" operations in pediatric solid tumors. J Pediatr Surg 1978, 13:275-280.
76. Grosfeld JL, Rescorla FJ, West KW, Goldman J Neuroblastoma in the first year of life: Clinical and biologic factors influencing outcome. Semin Pediatr Surg 1993, 2:37-46.
77. Grosfeld JL, Schatzlein M, Ballantine TVN, et al. Metastatic neuroblastoma: Factors influencing survival. J Pediatr Surg 1978, 13:59-65.
78. Grosfeld JL, West KW, Weber TR The role of second-look procedures in the management of retroperitoneal tumors in children. J Pediatr Hematol Oncol 1984, 6:441-447.
79. Haas D, Ablin AR, Miller C, et al. Complete pathologic maturation and regression of stage IV-S neuroblastoma without treatment. Cancer 1988, 62:818-825.
80. Haas-Kogan DA, Fisch BM, Wara WB, et al. Introperative radiation therapy for high risk neuroblastoma. Int J Radiat Oncol Biol Phys 2000, 47:985-992.
81. Haas-Kogan DA, Swift PS, Eslch M, et al. Impact of radiotherapy for high risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 2003, 56:28-39.
82. Haase GM Head and neck neuroblastomas. Semin Pediatr Surg 1994, 3:194-202.
83. Haase GM, LaQuaglia MP Neuroblastoma. Operative Pediatric Surgery 2003, 1181-1191. McGraw-Hill, New York. M. Ziegler, R.G. Azizkhan, T.R. Weber (Eds.).
84. Haase GM, O'Leary MC, Ramsay NK, et al. Aggressive surgery combined with intensive chemotherapy improves survival in poor risk neuroblastoma. J Pediatr Surg 1991, 26:1119-1123.
85. Haase GM, Wong KY, de Lorimier AA, et al. Improvement in survival after excision of the primary tumor in stage III neuroblastoma. J Pediatr Surg 1989, 24:194-200.
86. Haddad M, Triglia JM, Helardot P, et al. Localized cervical neuroblastoma: Prevention of surgical complications. Int J Pediatr Otorhinolaryngol 2003, 67:1361-1367.
87. Hann JL, et al. Serum ferritin levels as a guide to prognosis in stage IV neuroblastoma [abstract]. Proc Am Soc Clin Oncol 1983, 24:72.
88. Hatchitanda Y, Hata J Stage IV-S neuroblastoma: A clinical, histological and biological analysis. Hum Pathol 1996, 27:1135-1138.
89. Hayashi Y, Kanmda N, Inaba T, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 1989, 63:125-132.
90. Hayes FA, Green AA, Casper J, et al. Clinical evaluation of sequentially scheduled cisplatin and VM-26 in neuroblastoma: Response and toxicity. Cancer 1981, 48:1715-1718.
91. Hayes FA, Green AA, Hustu HO, Kumar ML Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatr 1983, 102:59-62.
92. Hayes F, Green AA, Mauer AM, et al. Correlation of cell kinetics and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res 1977, 37:3766-3770.
93. Heisel MA, Miller JH, Reid BS, Siegel SE Radionuclide bone scan in neuroblastoma. Pediatrics 1983, 71:206-209.
94. Hellstrom I, Hellstrom KE, Pierce GE, Bill AH Demonstration of cell bound humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A 1968, 60:1231-1238.
95. Hellstrom KE, Hellstrom I Lymphocyte mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol 1974, 18:209-217.
96. Helson L, Ghavimi F, Wu CJ, et al. Carcinoembryonic antigen in children with neuroblastoma. J Natl Cancer Inst 1976, 57:725-726.
97. Helson L, Helson C, Peterson RF, Das SK A rationale for the treatment of metastatic neuroblastoma. J Natl Cancer Inst 1976, 57:727-729.
98. Hiyama E, Yokoyama T, Hiyama K, et al. Multifocal neuroblastoma: Biologic behavior and surgical aspects. Cancer 2000, 88:1955-1963.
99. Hiyama E, Yokoyama T, Ichikawa T, et al. Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome. Cancer 1994, 74:1821-1826.
100. Ho R, Eggert A, Hishiki T, et al. Resistance to chemotherapy mediated by TrkB in neuroblastoma. Cancer Res 2002, 62:6462-6466.
101. Ho TC, Estroff JA, Kozakewich H, et al. Prenatal detection of neuroblastoma: A ten year experience from the Dana-Farber Cancer Institute and Children's Hospital. Pediatrics 1993, 92:358-364.
102. Holcomb GW Minimally invasive surgery for solid tumors. Semin Surg Oncol 1999, 7:184-192.
103. Holgersen LO, Subramanian S, Kirpekar M, et al. Spontaneous resolution of antenatally diagnosed adrenal masses. J Pediatr Surg 1996, 31:153-155.
104. Ikeda H, Iehara T, Tsuchida Y, et al. Experience with the International Neuroblastoma Staging System and pathology classification. Br J Cancer 2002, 86:1110-1116.
105. Ikeda H, Suzuki N, Takahashi A, et al. Surgical treatment of neuroblastomas in infants under 12 months of age. J Pediatr Surg 1998, 33:1246-1250.
106. Ishimoto K, Kiyokawa H, Fujita H, et al. Problems of mass screening for neuroblastoma: Analysis of false negative cases. J Pediatr Surg 1990, 25:398-401.
107. Iwanaka T, Arai M, Ito M, et al. Surgical treatment for abdominal neuroblastoma in the laparoscopic era. Surg Endosc 2001, 15:751-754.
108. Iwanaka T, Arai M, Kawashima H, et al. Endosurgical procedures for pediatric solid tumors. Pediatr Surg Int 2004, 20:39-42.
109. Jennings RW, LaQuaglia MP, Leong K, et al. Fetal neuroblastoma: Prenatal diagnosis and natural history. J Pediatr Surg 1993, 28:1168-1174.
110. Jiang TH, Yang CP, Hung IJ, et al. Brain metastases in children with neuroblastoma a single institution experience. Med Pediatr Oncol 2003, 41:570-571.
111. Joshi VV, Cantor AB, Altschuler G, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastoma. Cancer 1992, 69:2183-2196.
112. Kaicker S, McCRudden KW, Beck L, et al. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma. Int J Oncol 2003, 23:1651-1655.
113. 131-MIBG is effective for disease palliation in highly refractory neuroblastoma. J Pediatr Hematol Oncol 2003, 25:769. 763.
114. Kanold J, Halle P, Tchirkov A, et al. Ex-vivo expansion of autologous PB CD34+ cells provide a purge effect in children with neuroblastoma. Bone Marrow Transplant 2003, 32:485-488.
115. Kenney LB, Miller BA, Gloeker-Reis LA, et al. Increased incidence of cancer in infants in the United States 1980-1990. Cancer 1998, 82:1396-1400.
116. Kiely EM The surgical challenge of neuroblastoma. J Pediatr Surg 1994, 29:128-133.
117. Kim ES, Soffer SZ, Huang J, et al. Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J Pediatr Surg 2002, 37:518-522.
118. King D, Goodman J, Hawk T, et al. Dumbbell neuroblastoma in children. Arch Surg 1975, 110:888-891.
119. Kinney H, Faix R, Brazy J The fetal alcohol syndrome and neuroblastoma. J Pediatr 1980, 66:130-132.
120. Kogner P, Barbani G, Dominici C, et al. Co-expression of messenger RNA for Trk protooncogene and low affinity nerve growth factor receptors in neuroblastoma with favorable prognosis. Cancer Res 1993, 53:2044-2050.
121. Koh PS, Raffensperger J, Berry S, et al. Long-term outcome in children with opsoclonus myoclonus and ataxia and coincident neuroblastoma. J Pediatr 1994, 125:712-716.
122. Komuro H, Kaneko S, Kaneko M, et al. Expression of angiogenic factors and tumor progression in human neuroblastoma. J Cancer Res Clin Oncol 2001, 127:739-743.
123. Komuro H, Makino S, Tahara K Laparoscopic resection of an adrenal neuroblastoma detected by mass screening that grew in size during the observation period. Surg Endosc 2000, 14:297.
124. Koop CE, Schnaufer L The management of abdominal neuroblastoma. Cancer 1975, 35:905-909.
125. Kouch K, Yoshida H, Matsunaga T, et al. Extirpation of mass screened adrenal neuroblastoma by retroperitoneoscopy. Surg Endosc 2003, 17:1769-1772.
126. Kubota M, Yagi M, Kanada S, et al. Long-term follow up and status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy: A single institutional study. J Pediatr Surg 2004, 39:1328-1332.
127. Kudo K, Kitajima S, Munakata H, Yagihashi S WDHA syndrome caused by VIP-producing ganglioneuroblastoma. J Pediatr Surg 1982, 17:426-428.
128. Kumar AM, Wrenn EL, Fleming ID, et al. Preoperative therapy for unresectable malignant tumors in children. J Pediatr Surg 1975, 10:657-670.
129. Kushner BH, Cheung NK, LaQuaglia MP, et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996, 14:373-381.
130. Kushner BH, Kramer K, LaQuaglia MP, Cheung NK Curability of recurrent disseminated disease after surgery alone for loco-regional neuroblastoma using intensive chemotherapy and anti-GD-2 immunotherapy. J Pediatr Hematol Oncol 2003, 25:512-514.
131. Kushner BH, Kramer K, Modak S, Cheung NK Campothecin analogs (irinotecan or topotecan) plus high dose cyclophosphamide as preparative regimens for antibody based immunotherapy in resistant neuroblastoma. Clin Cancer Res 2004, 10:84-87.
132. Kushner BH, LaQuaglia MP, Bonilla MA, et al. Highly effective induction therapy for stage IV neuroblastomas in children over 1 year of age. J Clin Oncol 1994, 12:2607-2613.
133. Kushner BH, Wolden S, LaQuaglia MP, et al. Hyperfractionated low dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 2001, 19:2821-2828.
134. LaQuaglia MP, Kushner BH, Heller G, et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome. J Pediatr Surg 1994, 29:1162-1165.
135. LaQuaglia MP, Kushner BH, Su W, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 2004, 39:412-417.
136. Laug WE, Siegel SE, Shaw KN, et al. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 1978, 62:77-83.
137. 1 and papaverine. J Natl Cancer Inst 1977, 59:137-143.
138. Leavey PJ, Odom LF, Poole M, et al. Intraoperative radiation therapy in pediatric neuroblastoma. Med Pediatr Oncol 1997, 28:424-428.
139. Lee EW, Applebaum H Abdominal expansion as a bridging technique in stage IV-S neuroblastoma with massive hepatomegaly. J Pediatr Surg 1994, 29:1470-1471.
140. Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive neuroblastoma. Oncogene 1993, 8:855-865.
141. Luttikhuis ME, Powell JE, Rees SA, et al. Neuroblastoma with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer 2001, 85:531-537.
142. Mäkinen J Microscopic patterns as a guide to progno-sis of neuroblastoma in childhood. Cancer 1972, 29:1637-1646.
143. Marcus KJ, Shamberger R, Litman H, et al. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated in tandem double stem cell transplants. Pediatr Hematol Oncol 2003, 25:934-940.
144. Maris JM, Matthay KK The molecular biology of neuroblastoma. J Clin Oncol 1999, 17:2264-2279.
145. Maris JM, Weiss MJ, Mosse Y, et al. Evidence for a hereditary neuroblastoma predisposition locus at 16p12-13. Cancer Res 2002, 62:6651-6658.
146. Martinez-Mora J, Castellvi A, Coroleu W, et al. Cystic adrenal neuroblastoma: Prenatal diagnosis by ultrasonography. Med Pediatr Oncol 1995, 24:109-115.
147. Matsumura M, Tsunoda A, Nishi T, et al. Spontaneous regression of neuroblastoma detected by mass screening. Lancet 1991, 338:447-448.
148. Matthay KK Progress in the treatment of advanced stage neuroblastoma. Pediatric Neoplasms, Postgraduate Course, 82nd Clinical Congress Oct 1996, American College of Surgeons, San Francisco.
149. Matthay KK, Perez C, Seegar RC, et al. Treatment and outcome for stage III neuroblastoma based on prospective biology staging: A Children's Cancer Group study. J Clin Oncol 1998, 16:1256-1264.
150. Matthay KK, Seeger RC, Reynolds CP, et al. Allogeneic vs autologous purged bone marrow transplantation for neuroblastoma: A report from the Children's Cancer Group study. J Clin Oncol 1994, 12:2382-2389.
151. Matthay KK, Villlablanca JG, Seegar RC, et al. Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: A Children's Cancer Group study. N. Engl J Med 1999, 341:1165-1173.
152. McKallip R, Li R, Ladisch S Tumor gangliosides inhibit the tumor specific immune response. J Immunol 1999, 163:3718-3726.
153. Meitar D, Crawford SE, Rademaker AW, et al. Tumor angiogenesis correlates with metastatic disease, N-myc amplification and poor outcome in human neuroblastoma. J Clin Oncol 1996, 14:405-414.
154. Moertel CL, Reubi JC, Scheithauer BS, et al. Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 1994, 102:752-756.
155. Molofsky WJ, Chutorian AM Non-surgical treatment of intraspinal neuroblastoma. Neurology 1981, 31:1170-1173.
156. Moss TJ, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991, 324:219-226.
157. Nakagawara A, Arima M, Azar CG, et al. Inverse relationship between Trk expression and N-myc amplification in human neuroblastoma. Cancer Res 1992, 52:1364-1368.
158. Nakagawara A, Arima-Nakagawara M, Scavarda MG, et al. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastoma. N Engl J Med 1993, 328:847-854.
159. Nakagawara A, Azar CG, Scavardo NJ, et al. Expression and function of Trk-B and BDNF in human neuroblastomas. Mol Cell Biol 1994, 14:759-767.
160. Nakajima K, Fukuzawa M, Fukui Y, et al. Laparoscopic resection of mass screened adrenal neuroblastoma in an 8 month old infant. Surg Laparosc Endosc 1997, 7:498-500.
161. Nemecek ER, Sawin RW, Park J Treatment of neuroblastoma in patients with neurocristopathy syndromes. J Pediatr Hematol Oncol 2003, 25:159-162.
162. Nickerson HJ, Matthay KK, Seegar RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 2000, 18:477-486.
163. Nickerson HJ, Nesbit ME, Grosfeld JL, et al. Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 1985, 13:261-268.
164. Ninane J, Pritchard J, Jones Morris PH, et al. Stage II neuroblastoma: Adverse prognostic significance of lymph node involvement. Arch Dis Child 1982, 57:438-442.
165. Nitschke R, Cangir A, Crist W, Berry DH Intensive chemotherapy for metastatic neuroblastoma: A Southwest Oncology Group study. Med Pediatr Oncol 1980, 8:281-288.
166. Norris MD, Bordow SD, Marshall GM, et al. Expression of the gene for multidrug resistance associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996, 334:231-238.
167. Odelstad L, Pahlman S, Lackgren G, et al. Neuron specific enolase: A marker for differential diagnosis of neuroblastoma and Wilms' tumor. J Pediatr Surg 1982, 17:381-385.
168. Oue T, Fukuzawa M, Kusafuka T, et al. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression. J Pediatr Surg 1996, 31:251-257.
169. Oue T, Inoue M, Yoneda A, et al. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: Results of the Wait and See pilot study. J Pediatr Surg 2005, 40:359-363.
170. Paul SR, Tarbell NJ, Korf B, et al. Stage IV neuroblastoma in infants: Long-term survival. Cancer 1991, 67:1493-1497.
171. Pegelow CH, Ebbin AJ, Powars D, Towner JW Familial neuroblastoma. J Pediatr 1975, 87:763-765.
172. Perkins DG, Kopp CM, Haust MD Placental infiltration in congenital neuroblastoma. Histopathology 1980, 4:383-389.
173. Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 2003, 98:2274-2281.
174. Plantaz D, Rubie H, Michon J, et al. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease: A prospective study of 42 patients results of the NBL 90 study of the French Society of Pediatric Oncology. Cancer 1996, 3:521-525.
175. Ponzoni M, Bocca P, Chiesa V, et al. Differential effects of N-4-hydroxyphenylretinamide and retinoic acid on neuroblastoma cells: Apoptosis and differentiation. Cancer Res 1995, 55:853-861.
176. Powell JL, Buniz NJ, Callahan C, et al. An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma. Bone Marrow Transplant 2004, 33:651-657.
177. Prasad KN, Mandal B, Kumar S Demonstration of cholinergic cells in human neuroblastoma and ganglioneuroma. J Pediatr 1973, 82:677-679.
178. Pritchard J, McElwain TJ, Graham-Pole J High dose melphalan with autologous bone marrow for treatment of advanced neuroblastoma. Br J Cancer 1982, 45:86-94.
179. Qualman SJ, O'Diorisio MS, Fleshman DJ, et al. Neuroblastoma: Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 1992, 70:2005-2012.
180. Raffaghello L, Marimpietri D, Pagnan G, et al. Anti-GD2 monoclonal antibody immunotherapy: A promising strategy in the prevention of neuroblastoma relapse. Cancer Lett 2003, 197:205-209.
181. Redlinger RE, Shimizu T, Remy T, et al. Cellular mechanisms of interleukin-12 mediated neuroblastoma regression. J Pediatr Surg 2003, 38:199-204.
182. Redlinger RE, Mailliard RB, Barksdale EM Neuroblastoma and dendritic cell function. Semin Pediatr Surg 2004, 13:61-71.
183. Reynolds CP Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma. Curr Oncol Rep 2000, 2:511-518.
184. Reynolds CP, Kane DJ, Einhorn PA, et al. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 1996, 366:203-211.
185. Reynolds CP, Matthay KK, Villablanca JG, et al. Retinoid therapy of high risk neuroblastoma. Cancer Lett 2003, 197:185-192.
186. Ribatti D, Raffaghello L, Marimpietri D, et al. Fenretinide as an anti-angiogenic agent in neuroblastoma. Cancer Lett 2003, 197:181-184.
187. Richards ML, Gundersen AE, Williams MS Cystic neuroblastoma of infancy. J Pediatr Surg 1995, 30:1354-1357.
188. Rickard KA, Detamore CM, Coates TD, et al. Effect of nutrition staging on treatment delays and outcome in stage IV neuroblastoma. Cancer 1983, 52:587-598.
189. Rickard KA, Grosfeld JL, Kirksey A, et al. Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease. Ann Surg 1979, 190:771-781.
190. Rill DR, Santana VM, Roberts WM, et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994, 84:380-383.
191. Riley RD, Heney D, Jones DR, et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004, 10:4-12.
192. Rosenberg SA Development of effective immunotherapy for the treatment of patients with cancer. J Am Coll Surg 2004, 198:685-696.
193. Rowe DH, Huang J, Li J, et al. Suppression of primary tumor growth in a mouse model of human neuroblastoma. J Pediatr Surg 2000, 35:977-981.
194. Rubino C, Adjadj E, Guerin S, et al. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment. Int J Cancer 2003, 107:791-796.
195. Rudnick C, Khakoo Y, Antunes NL Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineural antibodies a report from the Children's Cancer Group study. Med Pediatr Oncol 2001, 36:612-622.
196. Russo C, Cohn SL, Petruzzi MJ, et al. Long term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group. Med Pediatr Oncol 1997, 28:284-288.
197. Sala A, Pencharz P, Barr RD Children, cancer and nutrition a dynamic triangle in review. Cancer 2004, 100:677-687.
198. Sandberg DI, Bilsky MH, Kushner BH, et al. Treatment of spinal involvement in neuroblastoma patients. Pediatr Neurosurg 2003, 39:291-298.
199. Sawada T, Sugimoto T, Kawakatsu H, et al. Mass screening for neuroblastoma in Japan. Pediatr Hematol Oncol 1991, 8:93-109.
200. Sawada T, Todo S, Fujita K, et al. Mass screening of neuroblastoma in infancy. Am J Dis Child 1982, 136:710-712.
201. Schilling FH, Parker C Mass screening in neuroblastoma: The European experience. Neuroblastoma 2000, 281-292. Elsevier, Amsterdam. G.M. Brodeur, T. Sawada, Y. Tsuchida, P.A. Vote (Eds.).
202. Schilling FH, Spix C, Berthold F, et al. German neuroblastoma mass screening study at 12 months of age: Statistical aspects and preliminary results. Med Pediatr Oncol 1998, 31:435-441.
203. Schleiermacher G, Rubie H, Hartmann O, et al. Treatment of stage 4s neuroblastoma report of 10 years experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer 2003, 89:470-476.
204. Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000, 18:1260-1268.
205. Schnaufer L, Koop CE Silastic abdominal pouch for temporary hepatomegaly in stage IV-S neuroblastoma. J Pediatr Surg 1975, 10:73-75.
206. Seeler RA, Israel JN, Royal JE, et al. Ganglioneuroblastoma and fetal hydantoin-alcohol syndrome. Pediatrics 1979, 63:524-527.
207. Senelick RC, Bray PF, Lahey ME, et al. Neuroblastoma and myoclonic encephalopathy: Two cases and a review of the literature. J Pediatr Surg 1973, 8:623-632.
208. Shimada H The International Neuroblastoma Pathology Classification. Pathologica 2003, 95:240-241.
209. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999, 86:349-363.
210. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999, 86:364-372.
211. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastoma: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma. J Natl Cancer Inst 1984, 73:405-416.
212. Shimada H, Stram DO, Chatten J, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995, 87:1470-1476.
213. Shimada H, Umehara S, Monobe Y, et al. International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer 2001, 92:2451-2461.
214. Shimizu T, Berhanu A, Redlinger RE, et al. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma. J Pediatr Surg 2001, 36:1285-1292.
215. Shorter NA, Davidoff AM, Evans AE, et al. The role of surgery in the management of stage IV neuroblastoma: A single institution study. Med Pediatr Oncol 1995, 24:287-291.
216. Shuster JJ, McWilliams MB, Castleberry R, et al. Serum lactate dehydrogenase in childhood neuroblastoma: A POG recursive partitioning study. Am J Clin Oncol 1992, 15:295-303.
217. Shusterman S, Grupp SA, Maris JM Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470. Med Pediatr Oncol 2000, 35:673-676.
218. Sitarz A, Finkelstein J, Grosfeld JL, et al. An evaluation of the role of surgery in disseminated neuroblastoma: A report from the Children's Cancer Study Group. J Pediatr Surg 1983, 18:147-151.
219. Spurbeck WW, Davidoff AM, Lobe TE, et al. Minimally invasive surgery in pediatric cancer patients. Ann Surg Oncol 2004, 11:340-343.
220. Squire R, Fowler CL, Brooks SP, et al. The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma. J Pediatr Surg 1990, 25:381-386.
221. Stevens MM Stage IV-S neuroblastoma: Disseminated malignancy with a favorable prognosis three case reports. Aust Paediatr J 1979, 15:39-43.
222. Stigall R, Smith WL, Francken EA, et al. Intrapulmonic metastatic neuroblastoma. Ann Radiol 1979, 22:223-227.
223. Suarez A, Hartmann O, Vassal G, et al. Treatment of stage IV-S neuroblastoma: A study of 34 cases treated from 1982-1987. Med Pediatr Oncol 1991, 19:473-477.
224. Sugio K, Nakagawara A, Sasazuki T Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected neuroblastoma. Cancer 1991, 67:1384-1388.
225. Suzuki T, Bogenmann, Shimada H, et al. Lack of high affinity nerve growth factor receptors in aggressive neuroblastoma. J Natl Cancer Inst 1993, 5:377-384.
226. Suzuki T, Yokota J, Mugishima H, et al. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 1989, 49:1095-1098.
227. Tanaka S, Tajiri T, Noguchi S, et al. Prenatally diagnosed cystic neuroblastoma: A report of 2 cases. Asian J Surg 2003, 26:225-227.
228. Tapia F, Polak JM, Barbosa AJ, et al. Neuron specific enolase is produced by neuroendocrine tumors. Lancet 1981, 1:808-811.
229. Tornoczky T, Kalman E, Kajtar PG, et al. Large cell neuroblastoma: A distinct phenotype of neuroblastoma with aggressive clinical behavior. Cancer 2004, 100:390-397.
230. Umehara S, Nakagawara A, Matthay KK, et al. Histopathology defines prognostic subsets of ganglioneuroblastoma nodular. Cancer 2000, 89:1150-1161.
231. Van Eys J, Copeland EM, Cangir A, et al. A clinical trial of hyperalimentation in children with metastatic malignancies. Med Pediatr Oncol 1980, 8:63-73.
232. Vertuani S, De Geer A, Levitsky V, et al. Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes. Cancer Res 2003, 63:8006-8013.
233. Villablanca JG, Khan AA, Avramis VI, et al. Phase I trial of 13 cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995, 13:894-901.
234. West KW, Weber TR, Grosfeld JL Synergistic effect of hyperthermia, papaverine and chemotherapy in murine neuroblastoma. J Pediatr Surg 1980, 15:913-917.
235. White L P-glycoprotein expression and progression of neuroblastoma. N Engl J Med 1992, 326:1162-1163.
236. Wilson PC, Coppes MJ, Solh H, et al. Neuroblastoma stage IV-S a heterogenous disease. Med Pediatr Oncol 1991, 19:467-472.
237. Woods W, Gaor N, Shuster JT, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002, 346:1041-1046.
238. Woods WG Screening for neuroblastoma: The final chapter. J Pediatr Hematol Oncol 2003, 25:3-4.
239. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998, 16:1265-1269.
240. Yamashiro DJ, Nakagawara A, Ikegaki N, et al. Expression of TrkC in favorable human neuroblastoma. Oncogene 1996, 12:37-41.
241. Yanik GA, Levine JE, Mattay KK, et al. Pilot study of metiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem cell support for the treatment of neuroblastoma. J Clin Oncol 2002, 20:2142-2149.
242. Yiin J, Chang CS, Jan YJ, Wang YC Treatment of neuroblastoma with intraspinal extension. J Clin Neurosci 2003, 10:579-583.
243. Young DG Thoracic neuroblastoma/ganglioneuroma. J Pediatr Surg 1983, 18:37-41.
244. Zeltzer PM, Marangos PJ, Parama AM, et al. Raised neuron specific enolase in the serum of children with metastatic neuroblastoma: A report from the Children's Cancer Study Group. Lancet 1983, 2:361-363.
245. Ziegler MM, Vega A, Koop CE Electrocoagulation induced immunity an explanation for regression of neuroblastoma. J Pediatr Surg 1980, 15:34-37.
246. Zimmerman RA, Bilaniuk CT CT of primary and secondary craniocerebral neuroblastoma. AJR Am J Roentgenol 1980, 135:1239-1242.